Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

These medications for BPH have known risks and may have new side effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Targeted photodynamic therapy is a promising method for precise disease treatment and diagnosis.

A new treatment for hair loss shows promise with fewer side effects.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

New compounds were made that are promising for prostate cancer therapy.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.